Type II pneumocytes, which synthesize, store, and secrete pulmonary surfact
ant, require exogenous fatty acids, in particular palmitic acid, for maximu
m surfactant synthesis. The uptake of palmitate by type II pneumocytes is t
hought to be protein mediated, but the protein involved has not been charac
terized. Here we show by RT-PCR and Northern blot analysis that rat type II
pneumocytes express the mRNA for fatty acid translocase (FAT/CD36), a memb
rane-associated protein that is known to facilitate the uptake of fatty aci
ds into adipocytes. The deduced amino acid sequence from rat type II pneumo
cytes reveals 98% identity to the FAT/CD36 sequence obtained from rat adipo
cytes. The uptake of palmitate by type II pneumocytes follows Michaelis-Men
ten kinetics (Michaelis-Menten constant = 11.9 +/- 1.8 nM; maximum velocity
= 62.7 +/- 5.8 pmol.min(-1).5 x 10(5) pneumocytes-l) and decreases reversi
bly under conditions of ATP depletion to 35% of control uptake. Incubation
of cells at 0 degrees C inhibited the uptake of palmitate almost completely
, whereas depletion of potassium was without effect. Preincubation of the c
ells with bromobimane or phloretin decreases the uptake of palmitate signif
icantly as does preincubation with sulfo-N-succinimidyl oleate, the specifi
c inhibitor of FAT/CD36 (C. M. Harmon, P. Luce, A. H. Beth, and N. A. Abumr
ad. J. Membr. Biol. 121: 261-268, 1991). From these data, we conclude that
FAT/CD36 is expressed in type II pneumocytes and mediates the uptake of pal
mitate in a saturable and energy-dependent manner. The data suggest that th
e uptake process is independent of the formation of coated pits and endocyt
otic vesicles.